Stock Alert: Interpace Biosciences Stock Up 20% In Extended Session

(RTTNews) - Interpace Biosciences Inc. (IDXG) announced a contract with Blue Cross Blue Shield of Massachusetts. Terms remain undisclosed. IDXG shares soared over 20% in after-hours session on March 11.

The stock has been trading between $3.80 and $11.00 in the past one year, and closed Wednesday's trade at $6.46, down 19 cents or 2.86%.

Interpace is an in-network lab with Blue Cross Blue Shield of Massachusetts for all product lines. The company continues to expand in-network agreements and medical coverage for its services with leading National and Regional health plans, while maintaining Medicare coverage through Novitas Solutions.